RXO

C.H. Robinson's stock fell 4.3% today following a 11% drop yesterday after announcing its acquisition of RXO for approximately $3 billion. Wall Street analysts Bank of America and Evercore lowered their price targets, citing concerns about capital dilution and deal timing, though both maintained buy-equivalent ratings. The company plans to suspend share buybacks and take on new debt to fund the acquisition, but expects the deal to be earnings accretive within nine months if it can achieve $300 million in synergies.

C.H. Robinson announced a $5.8 billion acquisition of RXO Inc. in a stock-and-cash transaction, with closing expected in the first half of 2027. The deal aims to generate nearly $300 million in net run-rate cost synergies within two years and is expected to be EPS-accretive within nine months of closing, with mid-teens adjusted EPS accretion projected for 2028.

The article discusses momentum investing strategies and highlights RXO (a transportation services provider) as a stock that combines recent price momentum with attractive valuation. RXO has shown a 38.7% four-week price change, a Zacks Rank #2 (Buy) rating, and trades at a low Price-to-Sales ratio of 0.78x, making it a candidate for investors seeking fast-moving stocks at reasonable prices.